SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
IVD Solutions
Menu
GB CL PSA
GB CL PSA is a high-sensitivity quantitative chemiluminescent reagent for total PSA in serum/plasma. Rapid 10-minute assay supports early prostate disease detection and monitoring. TFDA certified.
USEFUL RESOURCES
Add to List
>  PRODUCT DESCRIPTION>  PERFORMANCE>  SPECIFICATION>  ORDERING INFORMATION
PRODUCT DESCRIPTION
This in vitro diagnostic kit uses a chemiluminescent immunoassay with magnetic microparticles and a sandwich format to quantitatively measure total PSA in human serum or plasma. Requires 50 µL sample and delivers results in 10 minutes. Limit of quantification is 0.029 ng/mL. Storage at 2-8°C; avoid direct sunlight and freezing. CE certified. Ideal for early prostate disease detection, screening, and monitoring disease progression or therapy response.
PERFORMANCE
Limit of Quantitation (LoQ): 0.029 ng/mL
PrecisionVariabilityCoefficient of variation, CV (%)
Repeatabilitywithin run<10%
Reproducibilitybetween-run/between-day<10%
between-sites/between-operators<10%
between-lots<10%
SPECIFICATION
PrincipleSandwich-type chemiluminescent immunoassay 
Assay formatQuantification
Rreaction time10 minutes
Sample typeSerum/Plasma
Sample volume50 μL 
Detection unitRelative light unit (RLU)
Storage2-8°C. Avoid exposure to direct sunlight. Do not freeze.
CertificationTFDA
ORDERING INFORMATION
Catalogue No.Product
4APSA02GB CL PSA
4APSA1BGB CL PSA-Control
4APSA2BGB CL PSA-Calibrator